-
Rare mountain gorilla twins born in DR Congo: park authorities
-
Ex-midwife enthroned as first female Archbishop of Canterbury
-
AC Schnitzer: When Iconic Tuners Fall Silent
-
Senegal lodge appeal to Court of Arbitration for Sport over AFCON final decision
-
South Africa seal T20 series win in New Zealand
-
Study links major polluters to big climate damages bill
-
Ex-Google chief Matt Brittin made new BBC director-general
-
Iran likely behind attacks sowing fear among Europe's Jews: experts
-
'Relieved' McGrath claims career first crystal globe in slalom
-
US ski star Shiffrin wins overall World Cup title for sixth time
-
Trump names tech titans to science advisory council
-
Mideast war sparks long queues at Kinshasa petrol stations
-
US TV star details 'agony' over mother's disappearance
-
Tehran receives US plan to end Mideast war, as Iran fires at US carrier
-
Aviation, tourism, agriculture... the economic sectors hit by the war
-
Iran fires at US carrier as backchannel diplomacy aims to end war
-
Salah's long goodbye brings curtain down on golden era for Liverpool
-
Monaco: city of vice and a few virtues
-
AI making cyber attacks costlier and more effective: Munich Re
-
Defying Israeli bombs, Lebanese hold out in southern city of Tyre
-
War-linked power crunch pushes Sri Lanka to four-day week
-
Hungary says will phase out gas deliveries to Ukraine
-
Oil prices tumble, stocks rally on Mideast peace hopes
-
Maybach: Between Glory and a Turning Point
-
German business morale falls as war puts recovery on ice: survey
-
Labubu maker Pop Mart's shares fall 23% despite surging earnings
-
ECB won't be 'paralysed' in face of energy shock: Lagarde
-
Iran hits targets across Middle East after Trump signals talks progress
-
McEvoy says best is to come after breaking long-standing swim record
-
Goat vs gecko: A tiny Caribbean island faces wildlife showdown
-
Japan PM asks IEA chief to prepare additional 'coordinated release' of oil
-
Hungary's hard-pressed LGBTQ people say Orban exit is only half battle
-
Belarus leader visits North Korea for first time
-
'No heavier burden': the decades-long search for Kosovo war missing
-
Exotic pet trade thrives in China despite welfare concerns
-
Iran fires missile salvo after Trump signals progress in talks
-
BTS concert drew 18.4 million viewers, says Netflix
-
OSCE's 'chaotic' Ukraine evacuation put staff at risk: leaked report
-
Top WTO official sounds fertiliser warning over Middle East war
-
France and Brazil weigh up World Cup prospects in glamour friendly
-
Italy hoping to end World Cup pain as play-offs loom
-
Dirty diapers born again in Japan recycling breakthrough
-
Verstappen's Japan GP win streak under threat as Mercedes dominate
-
Crude tumbles, stocks rally on hopes for Iran war de-escalation
-
Gauff outlasts Bencic to reach Miami semi-finals
-
'Hero' Australian dog who saved 100 koalas retires
-
Underdogs chase World Cup berths in Mexico playoff tournament
-
Pope heads to tiny Catholic Monaco
-
Meet the four astronauts set to voyage around the Moon
-
Artemis 2 Moon mission: a primer
Czechs greenlight magic mushroom use from 2026
The outgoing Czech government said Wednesday it had approved the use of psilocybin -- the active ingredient in magic mushrooms -- for medical purposes from 2026.
Several countries have recently legalised the use by psychiatrists of the naturally occurring hallucinogenic compound, including New Zealand this year.
Lawmakers in the Czech Republic -- an EU and NATO member of 10.9 million people -- legalised the use of psilocybin in May, in an amendment to the penal code which also eased the rules for marijuana possession.
The government decision, which sets the rules for the drug's use, allows psychiatrists and psychotherapists to administer psilocybin if "treatment by registered medical substances is inefficient or if intolerance is proven".
They can only use psilocybin to treat cancer-related depression, clinically serious depression without psychotic symptoms and a worsened mental condition threatening the patient's life.
Health Minister Vlastimil Valek hailed the decision as beneficial for "the Czech health system, the expert public and patients".
In recent years, the therapeutic potential of psychedelic substances like psilocybin, as well as LSD and MDMA, has sparked renewed interest among scientists for treating depression and addiction.
New Zealand approved the use of psilocybin for depression treatment in June.
Germany allowed two clinics to use psilocybin within a "compassionate use programme", the first of its kind in the EU, in July.
Czech doctors have been allowed to prescribe medical cannabis since 2015, and cannabis treatment has been covered by public health insurance since 2020.
The centre-right Czech coalition government of right-winger Petr Fiala held its last meeting on Wednesday.
It will yield to a new coalition cabinet led by billionaire Andrej Babis, which is due to be sworn in next Monday following a general election in October.
O.Norris--AMWN